GLP-1-MEDICATIONS

GLP-1-MEDICATIONS

As GLP-1 Drug Shortage Ends, Why Will Patients Pay More?

The recent announcement by the FDA that the shortage of GLP1 weightloss medications such as Mounjaro and Zepbound is over has brought a mix of relief and anxiety to millions of patients across the United States. While the availability of these medications is a welcome development, concerns are rising about the affordability of these lifechanging treatments..

GLP-1-MEDICATIONS

How Do Weight Loss Drugs Actually Impact My Mental Health? A Therapist Explains

The Hidden Impact of Weight Loss Medications on Mental Health In recent years, the quest for a quick and effective way to lose weight has led many to turn to weight loss medications..

GLP-1-MEDICATIONS

A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating

The End of a LongRunning Shortage Brings Mixed Reactions October 9, 2024 A significant milestone in the medical world was achieved recently with the removal of Mounjaro and Zepbound, two popular glucagonlike peptide 1 (GLP1) medications, from the FDA's drug shortage list..